Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Bringing Light to Transcription: The Optogenetics Repertoire.

de Mena L, Rizk P, Rincon-Limas DE.

Front Genet. 2018 Nov 2;9:518. doi: 10.3389/fgene.2018.00518. eCollection 2018. Review.

2.

Short Aβ peptides attenuate Aβ42 toxicity in vivo.

Moore BD, Martin J, de Mena L, Sanchez J, Cruz PE, Ceballos-Diaz C, Ladd TB, Ran Y, Levites Y, Kukar TL, Kurian JJ, McKenna R, Koo EH, Borchelt DR, Janus C, Rincon-Limas D, Fernandez-Funez P, Golde TE.

J Exp Med. 2018 Jan 2;215(1):283-301. doi: 10.1084/jem.20170600. Epub 2017 Dec 5.

3.

secHsp70 as a tool to approach amyloid-β42 and other extracellular amyloids.

De Mena L, Chhangani D, Fernandez-Funez P, Rincon-Limas DE.

Fly (Austin). 2017 Jul 3;11(3):179-184. doi: 10.1080/19336934.2017.1291104. Epub 2017 Feb 6.

4.

Holdase activity of secreted Hsp70 masks amyloid-β42 neurotoxicity in Drosophila.

Fernandez-Funez P, Sanchez-Garcia J, de Mena L, Zhang Y, Levites Y, Khare S, Golde TE, Rincon-Limas DE.

Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):E5212-21. doi: 10.1073/pnas.1608045113. Epub 2016 Aug 16.

5.

Anti-Aβ single-chain variable fragment antibodies exert synergistic neuroprotective activities in Drosophila models of Alzheimer's disease.

Fernandez-Funez P, Zhang Y, Sanchez-Garcia J, de Mena L, Khare S, Golde TE, Levites Y, Rincon-Limas DE.

Hum Mol Genet. 2015 Nov 1;24(21):6093-105. doi: 10.1093/hmg/ddv321. Epub 2015 Aug 7.

6.

Modeling the complex pathology of Alzheimer's disease in Drosophila.

Fernandez-Funez P, de Mena L, Rincon-Limas DE.

Exp Neurol. 2015 Dec;274(Pt A):58-71. doi: 10.1016/j.expneurol.2015.05.013. Epub 2015 May 27. Review.

7.

Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms.

Cardo LF, Coto E, de Mena L, Ribacoba R, Mata IF, Menéndez M, Moris G, Alvarez V.

Neurosci Lett. 2014 Mar 6;562:45-9. doi: 10.1016/j.neulet.2014.01.009. Epub 2014 Jan 10.

PMID:
24418406
8.

No differential DNA methylation of PARK2 in brain of Parkinson's disease patients and healthy controls.

De Mena L, Cardo LF, Coto E, Alvarez V, Coto E.

Mov Disord. 2013 Dec;28(14):2032-3. doi: 10.1002/mds.25593. Epub 2013 Jul 18. No abstract available.

PMID:
23868535
9.

Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls.

Cardo LF, Coto E, de Mena L, Ribacoba R, Moris G, Menéndez M, Alvarez V.

J Neurol. 2013 May;260(5):1420-2. doi: 10.1007/s00415-013-6900-8. Epub 2013 Mar 30. No abstract available.

PMID:
23543376
10.

Mutational screening of PARKIN identified a 3' UTR variant (rs62637702) associated with Parkinson's disease.

de Mena L, Samaranch LL, Coto E, Cardo LF, Ribacoba R, Lorenzo-Betancor O, Pastor P, Wang L, Irigoyen J, Mata IF, Díaz M, Moris G, Menéndez M, Corao AI, Lorenzo E, Alvarez V.

J Mol Neurosci. 2013 Jun;50(2):264-9. doi: 10.1007/s12031-012-9942-y. Epub 2012 Dec 30.

PMID:
23275044
11.

A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.

Cardo LF, Coto E, de Mena L, Ribacoba R, Lorenzo-Betancor O, Pastor P, Samaranch L, Mata IF, Díaz M, Moris G, Menéndez M, Corao AI, Alvarez V.

J Mol Neurosci. 2012 Jul;47(3):425-30. doi: 10.1007/s12031-011-9669-1. Epub 2011 Nov 11.

PMID:
22076805
12.

Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.

Mata IF, Yearout D, Alvarez V, Coto E, de Mena L, Ribacoba R, Lorenzo-Betancor O, Samaranch L, Pastor P, Cervantes S, Infante J, Garcia-Gorostiaga I, Sierra M, Combarros O, Snapinn KW, Edwards KL, Zabetian CP.

Mov Disord. 2011 Apr;26(5):819-23. doi: 10.1002/mds.23642. Epub 2011 Mar 21.

13.

FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients.

de Mena L, Cardo LF, Coto E, Miar A, Díaz M, Corao AI, Alonso B, Ribacoba R, Salvador C, Menéndez M, Morís G, Alvarez V.

Neurosci Lett. 2010 Jul 19;479(1):22-5. doi: 10.1016/j.neulet.2010.05.019. Epub 2010 May 13.

PMID:
20471450
14.

Analysis of the Micro-RNA-133 and PITX3 genes in Parkinson's disease.

de Mena L, Coto E, Cardo LF, Díaz M, Blázquez M, Ribacoba R, Salvador C, Pastor P, Samaranch L, Moris G, Menéndez M, Corao AI, Alvarez V.

Am J Med Genet B Neuropsychiatr Genet. 2010 Sep;153B(6):1234-9. doi: 10.1002/ajmg.b.31086.

PMID:
20468068
15.

Mutational screening of the mortalin gene (HSPA9) in Parkinson's disease.

De Mena L, Coto E, Sánchez-Ferrero E, Ribacoba R, Guisasola LM, Salvador C, Blázquez M, Alvarez V.

J Neural Transm (Vienna). 2009 Oct;116(10):1289-93. doi: 10.1007/s00702-009-0273-2. Epub 2009 Aug 6.

PMID:
19657588
16.

Mitochondrial transcription factor A (TFAM) gene variation and risk of late-onset Alzheimer's disease.

Alvarez V, Corao AI, Alonso-Montes C, Sánchez-Ferrero E, De Mena L, Morales B, García-Castro M, Coto E.

J Alzheimers Dis. 2008 Apr;13(3):275-80.

PMID:
18430995
17.

Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.

Alvarez V, Corao AI, Sánchez-Ferrero E, De Mena L, Alonso-Montes C, Huerta C, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, García-Castro M, Coto E.

Neurosci Lett. 2008 Feb 13;432(1):79-82. doi: 10.1016/j.neulet.2007.12.010. Epub 2007 Dec 15.

PMID:
18248889

Supplemental Content

Loading ...
Support Center